Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/1998
05/22/1998CA2256692A1 Saccharide derivatives
05/22/1998CA2256674A1 1-galactose derivatives
05/22/1998CA2256016A1 1-thiogalactose derivatives
05/20/1998EP0843016A2 Staphylococcus FabD (malonylCoA:ACP transacylase) protein
05/20/1998EP0842945A2 Heterocycles as inhibitors of leukocyte adhesion and as antagonists of VLA-4
05/20/1998EP0842944A2 Heterocycles as inhibitors of leukocyte adhesion and as antagonists of VLA-4
05/20/1998EP0842943A2 5-Ring heterocycles as inhibitors of leukocyte adhesion and as VLA-4 antagonists
05/20/1998EP0842934A1 5-HT1F agonists
05/20/1998EP0842665A2 Interleukin-1 beta converting enzyme like apoptotic proteases and their agonists
05/20/1998EP0842664A1 Zinc-containing compositions for oral administration including a copper compound and an aminoacid
05/20/1998EP0842659A1 Use of estrogen agonists/antagonists for the manufacture of a medicament for the treatment of atherosclerosis
05/20/1998EP0842297A1 Methods of predicting the outcome of infection
05/20/1998EP0842278A1 Dnase-active protein
05/20/1998EP0842276A1 Method for reproducing in vitro the rna-dependent rna polymerase and terminal nucleotidyl transferase activities encoded by hepatitis c virus (hcv)
05/20/1998EP0842269A1 Mocarhagin, a cobra venom protease, and therapeutic uses thereof
05/20/1998EP0842268A2 Methods and compositions for identifying morphogen analogs
05/20/1998EP0842267A1 Mch2, AN APOPTOTIC CYSTEINE PROTEASE, AND COMPOSITIONS FOR MAKING AND METHODS OF USING THE SAME
05/20/1998EP0842196A1 Cell adhesion inhibitors
05/20/1998EP0842195A1 Peptide inhibitors of fibronectine
05/20/1998EP0842189A1 Early onset alzheimer's disease gene and gene products
05/20/1998EP0842175A1 Imidazopyridine derivatives
05/20/1998EP0842169A1 Benzothiophene compounds
05/20/1998EP0842165A1 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
05/20/1998EP0842161A1 4,5-diaryl oxazole derivatives
05/20/1998EP0842150A1 Novel farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing said inhibitors
05/20/1998EP0841950A1 Neuronal progenitor cells and uses thereof
05/20/1998EP0841937A1 Use of betaglycan to reduce scarring
05/20/1998EP0841935A1 Modulation of endothelial cell proliferation
05/20/1998EP0841929A1 Quinolones and their therapeutic use
05/20/1998EP0841925A1 Endothelin receptor antagonists
05/20/1998EP0841924A1 Benzimidazole compounds
05/20/1998EP0841919A1 Inhibitors of farnesyl-protein transferase
05/20/1998EP0841910A1 INHIBITION OF CoA-INDEPENDENT TRANSACYLASE AND APOPTOSIS
05/20/1998EP0841909A2 Use of alicyclic diamines as immunomodulators
05/20/1998EP0841908A1 1,3,3-(trisubstituted)cyclohex-1-ene dimers and related compounds
05/20/1998EP0841907A1 Use of agonists or antagonists of p 2? purinoceptors for the prevention of glutamate-evoked cytotoxicity
05/20/1998EP0824545A4 Peptide compositions with growth factor-like activity
05/20/1998EP0745091A4 Use of angiotensin ii analogs in tissue repair
05/20/1998EP0745083B1 2-HETEROARYL-5,11-DIHYDRO-6H-DIPYRIDO [3,2-b:2',3'-e][1,4]DIAZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION
05/20/1998EP0741708B1 Cyanoguanidines as k-channel blockers
05/20/1998EP0608336B1 Azabicyclo arylacetylene and arylenyne oximes as cholinergic agents and methods of treatment
05/20/1998EP0597997B1 Lanthionine bridged peptides
05/20/1998CN1182452A Osteoprotegerine
05/20/1998CN1182430A Carbohydrate conjugated bio-active compounds
05/20/1998CN1182427A Benzimidazole compounds and their use as modulators of the GABAA receptor complex
05/20/1998CN1182426A Benzimidazole compounds and their use as modulators of the GABAA receptor complex
05/20/1998CN1182425A Benzimidazole compounds and their use as modulators of the GABAA receptor complex
05/20/1998CN1182421A Quinazoline derivatives
05/20/1998CN1182417A Indole derivatives
05/20/1998CN1182369A Pharmaceutical compositions for controlled release of soluble receptors
05/20/1998CN1182367A Novel use of (S)-adenosyl -L -methnionine (SAMe)
05/20/1998CN1181937A Production process of medicated royal jelly
05/19/1998US5753710 Substituted benzyloxycarbonylguanidines, a process for their preparation, their use as a medicament or diagnostic, and a medicament containing them
05/19/1998US5753706 Methods for treating renal failure
05/19/1998US5753690 Treating psychoses
05/19/1998US5753684 By inhibiting the uptake of urea by macrophages and its conversion to urea
05/19/1998US5753682 Imidazole lipoxygenase inhibitors
05/19/1998US5753680 Heterocyclyl-benzoylguanidines
05/19/1998US5753673 Quinolinecarboxylic acid derivatives
05/19/1998US5753668 Substituted benzyloxypyrimidines and their inactivation of O6 -alkylguanine-DNA alkyltransferase
05/19/1998US5753662 Treating dopaminergic system disorders
05/19/1998US5753650 Inhibitors of farnesyl-protein transferase
05/19/1998US5753648 Tricyclic benzazepine vasopressin antagonists
05/19/1998US5753643 Heterocyclic compounds
05/19/1998US5753641 Method of treatment for benign prostatic hyperplasia
05/19/1998US5753635 Purine derivatives and their use as anti-coagulants
05/19/1998US5753624 Materials and methods for treatment of plaquing disease
05/19/1998US5753617 Peptide inhibitors of cellular adhesion
05/19/1998US5753505 Genetic expressing a marker, cell differentiation for treating nervous system disorder, alzheimer's disease
05/19/1998US5753263 Method to deliver compositions conferring resistance to alopecia to hair follicles
05/19/1998US5753221 Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions
05/15/1998CA2221090A1 Method of treating atherosclerosis
05/15/1998CA2220822A1 Heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/15/1998CA2220784A1 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/14/1998WO1998020146A2 Stabilized transient gene expression
05/14/1998WO1998020137A1 Human squalene epoxidase
05/14/1998WO1998020126A1 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
05/14/1998WO1998020119A1 Fatty-acid amide hydrolase
05/14/1998WO1998020118A1 Modified protein c and methods of use thereof
05/14/1998WO1998020110A1 HUMAN MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1 (MAdCAM-1) AND SPLICE VARIANTS THEREOF
05/14/1998WO1998020109A1 Pressure-mediated intracellular delivery of molecules or microparticles
05/14/1998WO1998020023A1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
05/14/1998WO1998020013A1 New knoevenagel condensation products, method for their production and their use
05/14/1998WO1998020011A1 3-CARBOXAMIDE DERIVATIVES OF 5H-PYRROLO[2,1-c][1,4]-BENZODIAZEPINES
05/14/1998WO1998020007A1 Quinolines and their therapeutic use
05/14/1998WO1998019999A1 N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity
05/14/1998WO1998019998A2 N-substituted 2-cyanopyrrolidines
05/14/1998WO1998019996A1 Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications
05/14/1998WO1998019705A1 Branched peptide linkers
05/14/1998WO1998019700A1 Treatment of inner ear hair cells
05/14/1998WO1998019697A2 Novel pharmaceutical compositions
05/14/1998WO1998019694A1 Therapeutic uses of bpi protein products in cystic fibrosis patients
05/14/1998WO1998019675A1 Use of conjugated linoleic acid to enhance natural killer lymphocyte function
05/14/1998WO1998010085A3 Gene therapy for congestive heart failure
05/14/1998WO1998007859A3 Secreted proteins and polynucleotides encoding them
05/14/1998WO1998005776A3 Secreted proteins and polynucleotides encoding them
05/14/1998CA2271013A1 Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications
05/14/1998CA2270973A1 New knoevenagel condensation products, method for their production and their use
05/14/1998CA2270927A1 Novel pharmaceutical compositions
05/14/1998CA2270293A1 Fatty-acid amide hydrolase
1 ... 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 ... 1564